ESR1 and ductal breast carcinoma in situ: Materials/Methods: Eligible women were age ≥ 50 years and s/p lumpectomy with negative sentinel nodes for estrogen receptor positive (ER+) invasive breast cancer (BC) without preoperative chemotherapy or any DCIS measuring ≤ 2.5 cm.